MAGNOSOLV 365 MG POR GRA SOL SCC 30

What is the maximum co-payment for MAGNOSOLV?

If the insurance company contributes, the maximum co-payment is 40,93 Kč. The maximum pharmacy price is 165,06 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below.

Does MAGNOSOLV have a counted co-payment set?

Yes, the medicine has a counted co-payment of 40,00 Kč. Learn more about the protective limit here.

How much does the insurance company pay for one dispensed reimbursed pack?

124,13 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Léčivý přípravek je hrazen v terapii onemocnění s prokázanou či suspektní hypomagnezémii. Léčivý přípravek není hrazen z prostředků veřejného zdravotního pojištění při podávání v podpůrné
a doplňkové léčbě jiných onemocnění, jejichž souvislost s hypomagnezémií není jasně prokázána.

Rychlý přehled

Dosage form Oral solution granules
Výdej Ne, lék nelze získat bez receptu.
Úhrada / doplatek / cena Ano, zkontrolujte ale specializaci předepisujícího lékaře níže. Maximální doplatek: 40,93 Kč. Maximální cena: 165,06 Kč.
Kdo může předepsat endocrinologyinternal medicineneurology, pediatric neurologypsychiatry, child and adolescent psychiatry, geriatric psychiatrygynecology and obstetrics, pediatric gynecologygeriatricskl…
Složení More information about the composition can be found in the SPC, section 6.1.
Dostupnost / výpadek Ukončeno The latest report from the manufacturer is from 14. 7. 2023. Výroba byla ukončena s platností od 20. 7. 2023. The manufacturer lists medicines with the following code as a potential substitute: 0270118
Kód SÚKL 0234736

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe MAGNOSOLV?

  • endocrinology
  • internal medicine
  • neurology, pediatric neurology
  • psychiatry, child and adolescent psychiatry, geriatric psychiatry
  • gynecology and obstetrics, pediatric gynecology
  • geriatrics
  • clinical oncology, pediatric oncology and hematology, radiation oncology and oncogynecology

What is the composition of MAGNOSOLV?

. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

  • Documents could not be found v lokální importní databázi.

Which medicines are similar to MAGNOSOLV?

The medicine belongs to ATC group A12CC30. Název skupiny není v lokální importní databázi dostupný.

Who manufactures MAGNOSOLV?

Informace o výrobci není dostupná.

Is the medicine in shortage?

The latest report from the manufacturer is from 14. 7. 2023. Production was terminated with effect from 20. 7. 2023. The manufacturer lists medicines with the following code as a potential substitute:

What is the unique code for MAGNOSOLV?

The medicine has code 0234736. Code details can be found here.

How many packs of MAGNOSOLV were previously dispensed on prescriptions in Czechia?

Show prescription medicine consumption

How many packs of MAGNOSOLV were previously dispensed on request forms in Czechia?

Show request-form medicine consumption

Z čeho se skládá maximální cena léku?

The page was last updated on 22. 06. 2026

SIMILAR MEDICINES: